The protective effect of ursodeoxycholic acid in alloxan-induced diabetes

Cell Biochemistry and Function

Volumn 22, Issue 2, 2004, Pages 97-103

  Lukivskaya, Oxana ^a   Lis, Ruslan ^b   Egorov, Alexander ^a   Naruta, Elena ^a   Tauschel, Horst Dietmar ^c   Buko, Vyacheslav U ^a  

^a INSTITUTE OF BIOCHEMISTRY   (Belarus)

^b GRODNO STATE MEDICAL UNIVERSITY   (Belarus)

^c Dr Falk Pharma GmbH   (Germany)

Author keywords

cells; Alloxan; Diabetes; Lipid peroxidation; Pancreas; Ursodeoxycholic acid

Indexed keywords

ALLOXAN; ANTIDIABETIC AGENT; INSULIN; MALONALDEHYDE; URSODEOXYCHOLIC ACID;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL FUNCTION; CELL GRANULE; CELL STRUCTURE; CONTROLLED STUDY; DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; INSULIN BLOOD LEVEL; LIPID PEROXIDATION; MALE; MORPHOMETRICS; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; RAT;

ANIMALS; BLOOD GLUCOSE; CHOLAGOGUES AND CHOLERETICS; CYTOPLASMIC GRANULES; DIABETES MELLITUS, EXPERIMENTAL; ISLETS OF LANGERHANS; MALE; RATS; TIME FACTORS; URSODEOXYCHOLIC ACID;

ANIMALIA;

EID: 1542314311     PISSN: 02636484     EISSN: None     Source Type: Journal    
DOI: 10.1002/cbf.1063     Document Type: Article

References (31)

1. Baynes JW, Thorpe SR. Role of oxidative stress in diabetic complications: a new perspective on an old paradigm. Diabetes 1999; 48: 1-9.
2. Kolb H. Mouse models of insulin-dependent diabetes: low-dose streptozotocin-induced diabetes and nonobese diabetic (NOD) mice. Diabetic Metab Rev 1987; 3: 751-778.
3. Hicks M, Delbridge L, Yue DK, Reeve TS. Catalysis of lipid peroxidation by glucose and glycosylated collagen. Biochim Biophys Res Commun 1988; 151: 649-655.
4. Mullarkey CJ, Edelstein D, Brownlee M. Free radical generation by early glycation products: a mechanism for accelerated atherogenesis in diabetes. Biochim Biophys Res Commun 1990; 173: 932-939.
5. Bucala R, Makita Z, Koschinsky T, Cerami A, Vlassara H. Lipid advanced glycosylation: pathway for lipid peroxidation in vivo. Proc Natl Acad Sci USA 1993; 90: 6436-6438.
6. Masukawa T, Nakanishi K, Katakawa J, Tetsumi T. Protection against alloxan-induced diabetes by various dialkyldithiocarbamates. Experientia 1995; 51: 29-31.
7. Kähler W, Kuklinski B, Rühlmann C, Plötz F. Diabetes mellitus - a free radical associated disease. Effects of adjuvant supplementation of antioxidants. In The Role of Antioxidants in Diabetes Mellitus, Greis FA, Wessel K (eds), ASTA Medical: Frankfurt, 1993; 33-53.
8. James OFW. Ursodeoxycholic acid treatment for chronic cholestatic liver disease. J Hepatol 1990; 11: 5-8.
9. Nguyen TD, Oliva L, Villard PH, et al. CYP2E1 and CYP3A1/2 gene expression is not associated with the ursodeoxycholate effect on ethanol-induced lipoperoxidation. Life Sci 1999; 65: 1103-1113.
10. Ljubuncic P, Tanne Z, Bomzon A. Ursodeoxycholic acid suppressed the effect of lipid peroxidation in diseased liver in experimental cholestatic liver disease. Digest Dis Sci 2000; 45: 1921-1928.
11. Buko VU, Lukivskaya O, Zavodnik LB, Sadovnichy VV, Petushok NE, Tauschel H-D. Antioxidative effect of ursodeoxycholic acid in the liver of rats with oxidative stress caused by gamma-irradiation. Ukrainian Biochem J 2002; 74: 88-93.
12. Poli G, Dianzani MU, Cheeseman KH, Slater TS, Lang J, Esterbauer H. Separation and characterization of the aldehydic products of lipid peroxidation stimulated by carbon tetrachloride or ADP-iron in isolated rat hepatocytes and rat liver microsomal suspension. Biochem J 1985; 227: 629-638.
13. Rice-Evans CA, Diplock AT, Symons MCR. Techniques in Free Radical Research. Elsevier: Amsterdam-London-New York-Tokyo, 1991; 145-149.
14. Watari N, Torizawa K, Kanai M, Sato T, Yokoi K. Ultrastructural studies on the preventive effect of ursodeoxycholic acid in possible alloxan-induced pancreatic injury. J Clin Electron Microscopy 1976; 9: 69-81.
15. Watari N, Mabuchi Y, Hotta Y. Electron microscopical observations on the curative effect of ursodesoxycholic acid in alloxan-induced pancreatic islet cell injury. Nippon Naibunpi Gakkai Zasshi 1977; 253: 1191-1201 (in Japanese).
16. Holtmeier J, Leuschner U. Medical treatment of primary biliary cirrhosis and primary sclerosing cholangitis. Digestion 2001; 64: 137-150.
17. Leuschner U, Güldutuna S, Bhatti S, Sipos T, You T, Zimmer G. Cytoprotection by ursodeoxycholic acid. In Cholestatic Liver Diseases: New Strategies for Prevention and Treatment of Hepatobiliary and Cholestatic Liver Diseases, Van Berge Henegouven GP, Van Hoek B, De Groote J, Matern S (eds). Kluwer Academic Press: Dordrecht-Boston-London, 1994; 218-225.
18. Plevris JN, Hayes PC, Bouchier AD. Ursodeoxycholic acid in the treatment of alcoholic liver disease. Eur J Gastroenterol Hepatol 1991; 3: 653-656.
19. Oliva L, Beauge F, Choquart D, Montet A-M, Guitaoui M, Montet J-C. Ursodeoxycholic acid alleviates alcoholic fatty liver damage in rats. Alcohol Clin Exp Res 1998; 22: 1538-1543.
20. Lukivskaya O, Maskevich A, Buko V. Effect of ursodeoxycholic acid on prostaglandin metabolism and microsomal membranes in alcoholic fatty liver. Alcohol 2001; 25: 99-105.
21. Tabouy L, Zamora AJ, Oliva L, Montet A-M, Beauge F, Montet J-C. Ursodeoxycholate protects against ethanol-induced liver mitochondrial injury. Life Sci 1998; 63: 2259-2270.
22. Sipos P, Güldutuna S, Leuschner U, Vallent K. Comparative study of superoxide production of monocytes in primary biliary cirrhosis. Orv Hetil 1995; 136: 2389-2392 (in Hungarian).
23. Lubuncic P, Fuhrman B, Oiknine J, Aviram M, Bomzon A. Effect of deoxycholic acid and ursodeoxycholic acid on lipid peroxidation in cultured macrophages. Gut 1996; 39: 475-478.
24. Rodrigues CMP, Fan G, Wong PY, Kren BT, Steer CJ. Ursodeoxycholic acid may inhibit deoxycholic acid-induced apoptosis by modulating mitochondrial transmembrane potential and reactive oxygen species production. Mol Med 1998; 4: 165-178.
25. Mitsuyoshi H, Nakashima T, Sumida Y, et al. Ursodeoxycholic acid protects hepatocytes against oxidative injury via induction of antioxidants. Biochem Biophys Res Commun 1999; 263: 537-542.
26. Jorns A, Tiedge M, Lenzen S, Munday R. Effect of superoxide dismutase, catalase, chelating agents, and free radical scavengers on the toxicity of alloxan to isolated pancreatic islets in vitro. Free Rad Biol Med 1999; 26: 1300-1304.
27. Sailaja Devi MM, Das SY. Preservation of the antioxidant status in chemically-induced diabetes mellitus by melatonin. J Pineal Res 2000; 29: 108-115.
28. Jain SK, McVie R, Smith T. Vitamin E supplementation restores glutathione and malondialdehyde to normal concentrations in erythrocytes of type I diabetic children. Diabetes Care 2000; 23: 1389-1394.
29. Aruna RV, Ramesh B, Kartha VN. Effect of betacarotene on protein glycosylation in alloxan induced diabetic rats. Indian J Exp Biol 1999; 37: 399-401.
30. Soto CP, Perez BL, Favari LP, Reyes JL. Prevention of alloxan-induced diabetes mellitus in the rat by silymarin. Comp Biochem Physiol Pharmacol Toxicol Endocrinol 1998; 119: 125-129.
31. Ho E, Chen G, Bray TM. Supplementation of N-acetylcysteine inhibits NFkappaB activation and protects against alloxan-induced diabetes in CD-1 mice. FASEB J 1999; 13: 1845-1854.